Avid Bioservices to Report Financial Results for Third

Avid Bioservices to Report Financial Results for Third

TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing......

Alvotech Announces Webcast of 2022 Full Year Financial

Alvotech Announces Webcast of 2022 Full Year Financial

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced......

Alvotech enters into commercialization agreement with

Alvotech enters into commercialization agreement with

Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area, UK, Switzerland, Canada, Australia,......

menu
menu